Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

BACKGROUND: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied systematically. METHODS: We identified patients at Memor...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Iwamoto, F M., Abrey, L E., Beal, K, Gutin, P H., Rosenblum, M K., Reuter, V E., DeAngelis, L M., Lassman, A B.
格式: Artigo
語言:Inglês
出版: American Academy of Neurology 2009
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839807/
https://ncbi.nlm.nih.gov/pubmed/19822869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181bc0184
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍